Literature DB >> 3000117

Effect of aging on growth hormone, ACTH and cortisol response to insulin-induced hypoglycemia in type I diabetes.

M Muggeo, P Moghetti, M Querena, S Girotto, E Bonora, G Crepaldi.   

Abstract

The influence of age on plasma growth hormone (GH) response to i.v. insulin (0.2 U/kg body weight) was evaluated in clinically stable type I (insulin-dependent) diabetics divided into four age groups (range 18.80 years). ACTH and cortisol were also assayed in two groups of diabetics under and over 50 years of age. A significant reduction with aging in GH response to insulin was observed. On the contrary, the glucose fall was similar in all the groups. ACTH and cortisol responses to insulin were slightly decreased in the older diabetics. Since insulin-induced hypoglycemia was similar in all the age groups, the progressive decline with aging in the GH response to insulin may be attributed to age-related changes of the pituitary gland. The data on ACTH and cortisol are less striking. Our data, as a whole, confirm that growth hormone response to insulin-induced glucose fall is not critical in acute glucose counterregulation in insulin-dependent diabetics. In fact, in spite of a 4-fold difference in GH levels, there was no difference in the 2-h glycemic course after 0.2 U/kg of i.v. insulin between young and aged patients. When a group of 26 type I diabetics with proliferative retinopathy was compared with a group of age-matched type I diabetics without retinopathy and with 30 age-matched normal subjects (injected i.v. with 0.1 U/kg body weight of insulin), no difference was found in GH response to insulin, indicating that GH hypersecretion is not a characteristic finding of diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3000117     DOI: 10.1007/bf02590790

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  27 in total

1.  Changes in the proportion of cell types in the anterior lobe of the human hypophysis during the first 19 years of life.

Authors:  A T RASMUSSEN
Journal:  Am J Anat       Date:  1950-01

2.  Influence of muscular exercise on plasma level of growth hormone in diabetics with and without retinopathy.

Authors:  P Passa; C Gauville; J Canivet
Journal:  Lancet       Date:  1974-07-13       Impact factor: 79.321

3.  Radioimmunoassay of human growth hormone.

Authors:  G M Molinatti; F Massara; E Strumia; F Pennisi; G A Scassellati; L Vancheri
Journal:  J Nucl Biol Med       Date:  1969 Jan-Jun

4.  Endogenous insulin and growth hormone response in children with newly diagnosed diabetes mellitus.

Authors:  A Drash; J B Field; L Y Garces; F M Kenny; D Mintz; A M Vazquez
Journal:  Pediatr Res       Date:  1968-03       Impact factor: 3.756

5.  Chronobiological pattern of growth hormone secretion in normal subjects and in retinopathic diabetics. Lack of suppression by a plurichronocorticoid drug.

Authors:  M Muggeo; M Molinari; A Baiocchi; A Tiengo; D Fedele; G Crepaldi
Journal:  Chronobiologia       Date:  1976 Oct-Dec

6.  Plasma corticosteroids determined by use of corticosteroid-binding globulin and dextran-coated charcoal.

Authors:  C A Nugent; D M Mayes
Journal:  J Clin Endocrinol Metab       Date:  1966-10       Impact factor: 5.958

7.  Growth hormone enhances basement membrane thickening in experimental diabetes. A preliminary report.

Authors:  R Osterby; K Seyer-Hansen; H J Gundersen; K Lundbaek
Journal:  Diabetologia       Date:  1978-12       Impact factor: 10.122

8.  Diabetes, diabetic angiopathy, and growth hormone.

Authors:  K Lundbaek; N J Christensen; V A Jensen; K Johansen; T S Olsen; A P Hansen; H Orskov; R Osterby
Journal:  Lancet       Date:  1970-07-18       Impact factor: 79.321

9.  Human growth hormone secretion after double stimulation with arginine in normal and insulin-dependent diabetic women.

Authors:  L Koncz; S Soeldner; M C Balodimos; G Boden; R E Gleason; D Younger
Journal:  Diabetes       Date:  1973-09       Impact factor: 9.461

10.  Abnormal serum growth hormone response to exercise in juvenile diabetics.

Authors:  A P Hansen
Journal:  J Clin Invest       Date:  1970-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.